BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7897323)

  • 21. Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice.
    Yagyu H; Ishibashi S; Chen Z; Osuga J; Okazaki M; Perrey S; Kitamine T; Shimada M; Ohashi K; Harada K; Shionoiri F; Yahagi N; Gotoda T; Yazaki Y; Yamada N
    J Lipid Res; 1999 Sep; 40(9):1677-85. PubMed ID: 10484615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice.
    Pastore L; Belalcazar LM; Oka K; Cela R; Lee B; Chan L; Beaudet AL
    Gene; 2004 Mar; 327(2):153-60. PubMed ID: 14980712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of macrophage-derived apolipoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apolipoprotein E-deficient mice.
    Spangenberg J; Curtiss LK
    Biochim Biophys Acta; 1997 Nov; 1349(2):109-21. PubMed ID: 9421184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice.
    Li H; Reddick RL; Maeda N
    Arterioscler Thromb; 1993 Dec; 13(12):1814-21. PubMed ID: 8241102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice.
    Sorci-Thomas MG; Zabalawi M; Bharadwaj MS; Wilhelm AJ; Owen JS; Asztalos BF; Bhat S; Thomas MJ
    Biochim Biophys Acta; 2012 Mar; 1821(3):502-12. PubMed ID: 21944998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E(Arg 112,Cys142).
    Fazio S; Sanan DA; Lee YL; Ji ZS; Mahley RW; Rall SC
    Arterioscler Thromb; 1994 Nov; 14(11):1873-9. PubMed ID: 7947615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor.
    Moore RE; Kawashiri MA; Kitajima K; Secreto A; Millar JS; Pratico D; Rader DJ
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1914-20. PubMed ID: 12933536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice.
    Christoffersen C; Jauhiainen M; Moser M; Porse B; Ehnholm C; Boesl M; Dahlbäck B; Nielsen LB
    J Biol Chem; 2008 Jan; 283(4):1839-47. PubMed ID: 18006500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrovirus-mediated expression of apolipoprotein A-I in the macrophage protects against atherosclerosis in vivo.
    Ishiguro H; Yoshida H; Major AS; Zhu T; Babaev VR; Linton MF; Fazio S
    J Biol Chem; 2001 Sep; 276(39):36742-8. PubMed ID: 11477092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined effects of cholesterol reduction and apolipoprotein A-I expression on atherosclerosis in LDL receptor deficient mice.
    Kawashiri MA; Zhang Y; Puré E; Rader DJ
    Atherosclerosis; 2002 Nov; 165(1):15-22. PubMed ID: 12208466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in mice.
    Tiniakou I; Kanaki Z; Georgopoulos S; Chroni A; Van Eck M; Fotakis P; Zannis VI; Kardassis D
    Atherosclerosis; 2015 Nov; 243(1):77-85. PubMed ID: 26363436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice.
    Joyce CW; Amar MJ; Lambert G; Vaisman BL; Paigen B; Najib-Fruchart J; Hoyt RF; Neufeld ED; Remaley AT; Fredrickson DS; Brewer HB; Santamarina-Fojo S
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):407-12. PubMed ID: 11752403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High levels of human apolipoprotein A-I and high density lipoproteins in transgenic mice do not enhance efflux of cholesterol from a depot of injected lipoproteins. Relevance to regression of atherosclerosis?
    Stein O; Dabach Y; Hollander G; Ben-Naim M; Halperin G; Stein Y
    Atherosclerosis; 1999 Jun; 144(2):367-74. PubMed ID: 10407497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of human apoA-I expression in mouse models of atherosclerosis after gene transfer using a second generation adenovirus.
    Tsukamoto K; Hiester KG; Smith P; Usher DC; Glick JM; Rader DJ
    J Lipid Res; 1997 Sep; 38(9):1869-76. PubMed ID: 9323596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HDL deficiency in genetically engineered mice requires elevated LDL to accelerate atherogenesis.
    Hughes SD; Verstuyft J; Rubin EM
    Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1725-9. PubMed ID: 9327769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice.
    Lou XJ; Boonmark NW; Horrigan FT; Degen JL; Lawn RM
    Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12591-5. PubMed ID: 9770530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The apolipoprotein(a) gene: characterization of 5' flanking regions and expression in transgenic mice.
    Lawn RM
    Chem Phys Lipids; 1994 Jan; 67-68():19-23. PubMed ID: 8187213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits.
    Duverger N; Kruth H; Emmanuel F; Caillaud JM; Viglietta C; Castro G; Tailleux A; Fievet C; Fruchart JC; Houdebine LM; Denefle P
    Circulation; 1996 Aug; 94(4):713-7. PubMed ID: 8772693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice reduces atherogenesis in response to a high fat-high cholesterol diet.
    Baroukh N; Ostos MA; Vergnes L; Recalde D; Staels B; Fruchart J; Ochoa A; Castro G; Zakin MM
    FEBS Lett; 2001 Jul; 502(1-2):16-20. PubMed ID: 11478940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paradoxical effects of fenofibrate and nicotinic acid in apo E-deficient mice.
    Declercq V; Yeganeh B; Moshtaghi-Kashanian GR; Khademi H; Bahadori B; Moghadasian MH
    J Cardiovasc Pharmacol; 2005 Jul; 46(1):18-24. PubMed ID: 15965350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.